ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
30.04
-0.29 (-0.96%)
At close: Apr 28, 2026, 4:00 PM EDT
30.15
+0.11 (0.37%)
After-hours: Apr 28, 2026, 7:44 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.33 billion as of April 28, 2026. Its market cap has increased by 131.52% in one year.
Market Cap
1.33B
Enterprise Value
1.02B
1-Year Change
131.52%
Ranking
Category
Stock Price
$30.04
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.33B, an increase of 130.84%. That is a compound annual growth rate of 44.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.34B | 61.41% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.46B |
| Maze Therapeutics | 1.44B |
| Precigen | 1.43B |
| Viridian Therapeutics | 1.41B |
| Olema Pharmaceuticals | 1.37B |
| Savara | 1.35B |
| Wave Life Sciences | 1.35B |
| Corvus Pharmaceuticals | 1.34B |